Funder
National Health and Medical Research Council
Bristol-Myers Squibb
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference59 articles.
1. Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, et al. American Society of Clinical Oncology Statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33(23):2563–77.
2. Wang Y, Qiu T, Zhou J, Francois C, Toumi M. Which criteria are considered and how are they evaluated in health technology assessments? A review of methodological guidelines used in Western and Asian countries. Appl Health Econ Health Policy. 2021;19(3):281–304.
3. Weinstein M, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;11:S5–9.
4. Pizzi LT. The Institute for Clinical and Economic Review and its growing influence on the US healthcare. Am Health Drug Benefits. 2016;9(1):9–10.
5. ICER. Institute for Clinical and Economic Review 2020-2023 Value Assessment Framework. 2021. https://icer.org/wp-content/uploads/2022/01/ICER_2020_2023_VAF_120821.pdf.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献